XML 29 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Unaudited Condensed Consolidated Statements of Cash Flows (Q2) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net income $ 1,293,284 $ 4,921,380
Adjustments to reconcile net income to net cash used in operating activities:    
Interest income on cash and marketable securities held in Trust Account (1,964,386) (234,500)
Change in fair value of convertible note (58,590)
Change in fair value of warrant liabilities (433,738) (5,172,523)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 88,292 137,925
Accrued offering costs and expenses (21,461) 23,823
Income tax payable (136,336) 26,522
Due to related party 30,000 3,387
Deferred tax liability (36,940)
Net cash used in operating activities (1,239,875) (293,986)
Cash flows from investing activities:    
Payment of extension fee into Trust Account (194,827)
Cash withdrawn from Trust Account in connection with redemption 184,845,836
Reimbursement by related party 25,000
Reimbursement of franchise and income taxes from Trust Account 877,438 8,484
Net cash provided by (used in) investing activities 185,528,447 33,484
Cash flows from financing activities:    
Proceeds from convertible promissory note 369,589
Redemption of common stock (184,845,836)
Net cash provided by (used in) financing activities (184,476,247)
Net change in cash (187,675) (260,502)
Cash, beginning of the period 193,486 741,228
Cash, end of the period 5,811 480,726
Supplemental disclosure of cash flow information:    
Income taxes paid, inclusive of interest and penalties 597,437
Excise tax payable attributable to redemption of common stock 1,848,455
Accretion of common stock to redemption value $ 1,699,287 $ 132,478